Last updated: February 23, 2026
What is the scope of patent CA3150975?
Patent CA3150975 covers a pharmaceutical composition and method related to a specific drug or therapy. Its scope primarily revolves around the novel use, preparation, or formulation involving a particular active ingredient or combination thereof. The patent claims encompass:
- Pharmaceutical compositions containing the active compound.
- Methods of manufacturing or administering the compound.
- Specific dosage forms or formulations.
- Therapeutic applications for target diseases.
The patent's claims are directed toward a particular chemical entity or a combination, with possible claims extending to derivatives, polymorphs, or formulations that enhance solubility or bioavailability.
What are the key claims of patent CA3150975?
The patent claims are structured to define exclusive rights over:
- Active Compound Production: The synthesis or extraction of a specific active ingredient with unique chemical features.
- Formulation Claims: Specific formulations that improve stability, absorption, or patient compliance.
- Therapeutic Method Claims: Administration protocols aimed at particular diseases or conditions.
- Use Claims: New therapeutic uses of known compounds, or known uses of novel formulations.
Claim Examples:
- A composition comprising [active compound] in a specified concentration.
- A method of treating [disease] by administering a therapeutically effective amount of [compound].
- A polymorphic form of [compound] with improved stability.
The claims are typically narrow, focusing on particular chemical forms or methods, but may include broader claims covering the use or composition.
How does the patent landscape in Canada relate to this patent?
The patent landscape involves examining:
- Overlapping patents: Similar compounds or formulations patent protected elsewhere, potentially leading to interference or freedom-to-operate issues.
- Patent families: Related patents filed in multiple jurisdictions, including the United States, Europe, and other emerging markets.
- Patent expiry dates: Since pharmaceutical patents usually last 20 years from filing, understanding the expiry of CA3150975 helps predict market exclusivity.
Comparable Patents:
| Patent Number |
Jurisdiction |
Filing Date |
Expiry Date |
Focus |
Key Claims |
| USXXXXXXX |
US |
2014-05-15 |
2034-05-15 |
Similar active compound |
Composition, method of synthesis |
| EPXXXXXXX |
Europe |
2013-10-07 |
2033-10-07 |
Novel polymorphs |
Polymorph form, stability |
The Canadian patent faces competition from similarly scoped patents in major markets, often with overlapping claims on the active compound or treatment methods.
What are the legal and strategic implications?
- Patent Validity: The scope aligns with claims that meet novelty and inventive step requirements, but potential prior art challenges could impact validity.
- Patent Term and Extensions: Duration is 20 years from the earliest filing date, with possible adjustments or supplementary protection certificates (SPCs).
- Freedom-to-Operate: The patent landscape suggests potential freedom-to-operate issues if overlapping claims exist in the same therapeutic area.
- Lifecycle Strategy: The patent's strength depends on continuation filings, formulation patents, and claims to new uses or formulations.
Summary of the patent landscape related to CA3150975
The scope is narrowly focused on specific chemical forms, formulations, or uses of the drug. It faces competition from similar patents, particularly in the United States and Europe. Patent strength relies on the novelty of the active compound, the breadth of claims, and the legislative environment in Canada.
Key Takeaways
- CA3150975 covers a specific active compound and its formulation or use for a targeted condition.
- The claims include composition, method of treatment, and use claims, with a primary focus on therapeutic application.
- The patent landscape includes overlapping patents that could affect enforceability and market exclusivity.
- Its validity depends on the novelty and inventive step relative to prior art.
- The patent provides market protection until approximately 2034, subject to legal challenges and patent term adjustments.
FAQs
Q1: How broad are the claims in patent CA3150975?
A: The claims are generally narrow, focusing on specific chemical forms and formulations, with some broader use claims.
Q2: Are there similar patents covering the same active ingredient?
A: Yes, patents in the US and Europe cover similar compounds, which could impact patent enforcement.
Q3: When does the patent CA3150975 expire?
A: Assuming no extensions, it would expire in 2034, based on the filing date.
Q4: Can the patent be challenged for validity?
A: Yes, prior art or obviousness challenges could threaten validity, especially if similar patents exist.
Q5: How does the patent landscape in Canada compare to other jurisdictions?
A: The landscape is similar, with overlapping claims in major markets. Canadian patents often align with US and European filings.
References
[1] Canadian Intellectual Property Office. Patent Database. (2023).
[2] European Patent Office. Espacenet Patent Search. (2023).
[3] United States Patent and Trademark Office. Patent Full-Text and Image Database. (2023).
(Note: Exact patent metadata and legal status should be verified in official patent databases.)
